Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Colosimo

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 20, 2025
A European perspective on tardive dyskinesiaCarlo Colosimo, Rakesh Jain, Krzysztof Duma, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 17, 2008
The PRIAMO study: background, methods and recruitmentAngelo Antonini, Carlo Colosimo, Roberto Marconi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 2025
Fluid biomarkers in atypical Parkinsonism: current state and future perspectivesAnastasia Bougea, Carlo Colosimo, Cristian Falup-Pecurariu, et al.
Journal of the Neurological Sciences|July 19, 2020
Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.
Neural Regeneration Research|August 12, 2021
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamineAngela De Iuliis, Ennio Montinaro, Giuseppe Fatati, et al.
Nature Clinical Practice. Neurology|February 6, 2009
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatmentGiovanni Fabbrini, Giovanni Defazio, Carlo Colosimo, et al.
Acta Neurologica Belgica|July 19, 2020
Letter to the editor: "COVID-19 does not reduce stroke-related emergencies"Stefano Caproni, Chiara Di Schino, Franco Costantini, et al.
Journal of Neurology|September 11, 2019
How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.
Functional Neurology|March 7, 2014
Use of botulinum toxin type A in the management of patients with neurological disorders: a national surveyNicola Smania, Carlo Colosimo, Anna Rita Bentivoglio, et al.
Journal of Neurology|October 10, 2019
Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 20, 2025
A European perspective on tardive dyskinesiaCarlo Colosimo, Rakesh Jain, Krzysztof Duma, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 17, 2008
The PRIAMO study: background, methods and recruitmentAngelo Antonini, Carlo Colosimo, Roberto Marconi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 2025
Fluid biomarkers in atypical Parkinsonism: current state and future perspectivesAnastasia Bougea, Carlo Colosimo, Cristian Falup-Pecurariu, et al.
Journal of the Neurological Sciences|July 19, 2020
Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.
Neural Regeneration Research|August 12, 2021
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamineAngela De Iuliis, Ennio Montinaro, Giuseppe Fatati, et al.
Nature Clinical Practice. Neurology|February 6, 2009
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatmentGiovanni Fabbrini, Giovanni Defazio, Carlo Colosimo, et al.
Acta Neurologica Belgica|July 19, 2020
Letter to the editor: "COVID-19 does not reduce stroke-related emergencies"Stefano Caproni, Chiara Di Schino, Franco Costantini, et al.
Journal of Neurology|September 11, 2019
How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.
Functional Neurology|March 7, 2014
Use of botulinum toxin type A in the management of patients with neurological disorders: a national surveyNicola Smania, Carlo Colosimo, Anna Rita Bentivoglio, et al.
Journal of Neurology|October 10, 2019
Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational studyCarlo Colosimo, David Charles, Vijay P Misra, et al.
Pageof 17